FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

715255009: Asfotase alfa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2016. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3302007016 Asfotase alfa (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3302014019 Asfotase alfa en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Asfotase alfa Is a Alkaline phosphatase true Inferred relationship Existential restriction modifier
Asfotase alfa Has disposition Phosphoric monoester hydrolase true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing asfotase alfa Has active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier 1
Product containing asfotase alfa in parenteral dose form (medicinal product form) Has active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier 1
Asfotase alfa Has active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier 1
Product containing only asfotase alfa in parenteral dose form (medicinal product form) Has active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier 1
Strensiq 18mg/0.45ml solution for injection vials (Alexion Pharma UK Ltd) Has specific active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Asfotase alfa 18mg/0.45ml solution for injection vials Has specific active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Asfotase alfa 28mg/0.7ml solution for injection vials Has specific active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Asfotase alfa 40mg/1ml solution for injection vials Has specific active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Asfotase alfa 80mg/0.8ml solution for injection vials Has specific active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Strensiq 28mg/0.7ml solution for injection vials (Alexion Pharma UK Ltd) Has specific active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Strensiq 40mg/1ml solution for injection vials (Alexion Pharma UK Ltd) Has specific active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Strensiq 80mg/0.8ml solution for injection vials (Alexion Pharma UK Ltd) Has specific active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Asfotase alfa 80mg/0.8ml solution for injection vials 12 vial Has specific active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Asfotase alfa 40mg/1ml solution for injection vials 12 vial Has specific active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Asfotase alfa 28mg/0.7ml solution for injection vials 12 vial Has specific active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Asfotase alfa 18mg/0.45ml solution for injection vials 12 vial Has specific active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Strensiq 18mg/0.45ml solution for injection vials (Alexion Pharma UK Ltd) 12 vial Has specific active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Strensiq 28mg/0.7ml solution for injection vials (Alexion Pharma UK Ltd) 12 vial Has specific active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Strensiq 40mg/1ml solution for injection vials (Alexion Pharma UK Ltd) 12 vial Has specific active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Strensiq 80mg/0.8ml solution for injection vials (Alexion Pharma UK Ltd) 12 vial Has specific active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Asfotase alfa 18mg/0.45ml solution for injection vials Has active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
Asfotase alfa 28mg/0.7ml solution for injection vials Has active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
Asfotase alfa 40mg/1ml solution for injection vials Has active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
Asfotase alfa 80mg/0.8ml solution for injection vials Has active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
Strensiq 18mg/0.45ml solution for injection vials (Alexion Pharma UK Ltd) Has active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Strensiq 28mg/0.7ml solution for injection vials (Alexion Pharma UK Ltd) Has active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Strensiq 40mg/1ml solution for injection vials (Alexion Pharma UK Ltd) Has active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier
Strensiq 80mg/0.8ml solution for injection vials (Alexion Pharma UK Ltd) Has active ingredient True Asfotase alfa Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start